Investigations of anticholinestrase and antioxidant potentials of methanolic extract, subsequent fractions, crude saponins and flavonoids isolated from Isodon rugosus
© Zeb et al.; licensee BioMed Central. 2014
Received: 8 September 2014
Accepted: 18 December 2014
Published: 26 December 2014
Based on the ethnomedicinal uses and the effective outcomes of natural products in various diseases, this study was designed to evaluate Isodon rugosus as possible remedy in oxidative stress, alzheimer’s and other neurodegenerative diseases. Acetylecholinestrase (AChE) and butyrylcholinesterase (BChE) inhibitory activities of crude methanolic extract (Ir.Cr), resultant fractions (n-hexane (Ir.Hex), chloroform (Ir.Cf), ethyl acetate (Ir.EtAc), aqueous (Ir.Aq)), flavonoids (Ir.Flv) and crude saponins (Ir.Sp) of I. rugosus were investigated using Ellman’s spectrophotometric method. Antioxidant potential of I. rugosus was determined using DPPH, H2O2 and ABTS free radicals scavenging assays. Total phenolic and flavonoids contents of plant extracts were determined and expressed in mg GAE/g dry weight and mg RTE/g of dry sample respectively.
Among different fractions Ir.Flv and Ir.Cf exhibited highest inhibitory activity against AChE (87.44 ± 0.51, 83.73 ± 0.64%) and BChE (82.53 ± 0.71, 88.55 ± 0.77%) enzymes at 1 mg/ml with IC50 values of 45, 50 for AChE and 40, 70 μg/ml for BChE respectively. Activity of these fractions were comparable to galanthamine causing 96.00 ± 0.30 and 88.61 ± 0.43% inhibition of AChE and BChE at 1 mg/ml concentration with IC50 values of 20 and 47 μg/ml respectively. In antioxidant assays, Ir.Flv, Ir.Cf, and Ir.EtAc demonstrated highest radicals scavenging activities in DPPH and H2O2 assays which were comparable to ascorbic acid. Ir.Flv was found most potent with IC50 of 19 and 24 μg/ml against DPPH and H2O2 radicals respectively. Whereas antioxidant activates of plant samples against ABTS free radicals was moderate. Ir.Cf, Ir.EtAc and Ir.Cr showed high phenolic and flavonoid contents and concentrations of these compounds in different fractions correlated well to their antioxidant and anticholinestrase activities.
It may be inferred from the current investigations that the Ir.Sp, Ir.Flv and various fractions of I. rugosus are good sources of anticholinesterase and antioxidant compounds. Different fractions can be subjected to activity guided isolation of bioactive compounds effective in neurological disorders.
KeywordsAnticholinesterase Antioxidant Flavonoids Phenolics Saponins Isodon rugosus
Alzheimer's disease (AD) is a chronic neurodegenerative disorder effecting more than twenty millions people globally and is the most common cause of dementia in elder population [1, 2]. AD is characterized by degeneration of neurological function, presence of extra-neuronal amyloid deposits, neuritic plaques, gradual deficits in various neurotransmitters leading to decline in the levels of acetylcholine (ACh) and loss of cognitive abilities . Inhibitors of acetylecholinestrase (AChE) and butyrylcholinestrase (BChE), key enzymes involved in the degradation of neurotransmitter ACh, have been shown to function by restoring the level of ACh in the synaptic region and thus reinstate deficient cholinergic neurotransmission [3, 4]. Since the discovery of cholinergic deficits in patients suffering from neurological disorders, inhibition of these enzymes is the main target in the treatment of AD, senile dementia, Parkinsonism, ataxia and myasthenia gravis [5, 6]. Synthetic drugs used in the treatment of cognitive dysfunction associated with AD and other diseases include tacrine, donepezil and rivastigmine . But these drugs are associated with adverse effects including gastrointestinal disturbances, hepatotoxicity and bioavailability problems [8, 9], which necessitates the development of better AChE and BChE inhibitors from natural resources i.e. galantamine.
Reactive oxygen species (ROS) are produced during aerobic respiration and other redox processes in the body. These ROS can attack some important biomolecules like enzymes, lipids, proteins, DNA and RNA leading to cellular damage and plays a major role in aging process . To counteract oxidative stress, human body has several defense mechanisms including antioxidant enzymes and non-enzymatic compounds. But excess of free radicals make the organism unable to scavenge all ROS. These ROS are implicated in the development of some chronic diseases including cardiovascular diseases, cancer, diabetes, nephritis, rheumatism and aging. Oxidative stress has been reported to play a key role in the progression of neurodegenerative diseases like AD and Parkinson's disease [11, 12]. Generally consumption of herbs, fruits and vegetables are beneficial for health due to the presence of protective antioxidant phyto-nutrients present in them [13, 14]. Synthetic antioxidant compounds including gallic acid esters, butylated hydroxy toluene (BHT), tertiary butylated hydroquinone and butylated hydroxy anisole (BHA) are associated with severe adverse effects and hence their use is limited. Consequently, there is need to discover new antioxidants from natural sources . In this regard antioxidant potential of numerous plants has been reported [16–19]. In antioxidant compounds, flavonoids and phenolic compounds are very important. These compounds has the ability to scavenge free radicals effectively due to the presence of hydroxyl groups and conjugated system .
I. rugosus belongs to Labiateae, a family rich in species containing huge number of pharmacologically active compounds. The Isodon species are traditionally used as anticancer, antimicrobial, insecticidal, antioxidants and as anthelmintic [21–24]. I. rugosus is used traditionally in the management of hypertension, rheumatism, tooth-ache, and pyrexia . Ethno-medicinally, this is used in the treatment of skin diseases, ear, nose and throat infections and the treatment of intestinal disorders are also reported . In an effort to discover new sources which can potentially be used in the treatment of oxidative stress, AD and other neurological disorders, I. rugosus was investigated for anticholinesterase and antioxidant potentials.
Total phenolic and flavonoid contents
Total phenolics and total flavonoids of Ir.Cr and subfractions of I . rugosus
Total phenolics (mg GAE/g of sample)
Total flavonoids (mg RTE/g of sample)
65.51 ± 1.67
71.73 ± 0.69
41.38 ± 1.15
44.40 ± 2.76
82.60 ± 0.68
91.45 ± 1.12
67.45 ± 0.83
68.46 ± 1.83
18.11 ± 2.25
27.12 ± 1.33
Percent AChE and BChE inhibition potentials of I. rugosus at various tested concentrations
Percent AChE (mean ± SEM)
(mean ± SEM)
77.85 ± 0.56***
69.48 ± 0.74***
71.64 ± 0.75***
62.62 ± 0.40***
62.58 ± 0.77***
51.60 ± 0.46***
71.75 ± 0.63***
68.68 ± 0.49***
63.58 ± 0.70***
61.72 ± 0.66***
56.61 ± 0.53***
55.46 ± 0.63***
64.79 ± 0.62***
62.61 ± 0.77***
45.45 ± 0.49***
54.60 ± 0.80***
43.75 ± 0.58***
43.83 ± 0.56***
83.73 ± 0.64***
88.55 ± 0.77ns
79.47 ± 0.56***
83.65 ± 0.77ns
67.81 ± 0.60***
67.58 ± 0.74***
71.74 ± 0.61***
76.37 ± 0.68***
69.68 ± 0.60***
72.66 ± 0.78***
52.63 ± 0.76***
63.62 ± 0.74***
66.79 ± 0.63***
71.62 ± 0.74***
59.67 ± 0.61***
63.86 ± 0.60***
41.69 ± 0.77***
44.48 ± 0.64***
87.44 ± 0.51***
82.53 ± 0.71***
73.76 ± 0.58***
76.52 ± 0.68***
71.54 ± 0.50***
68.51 ± 0.77***
96.00 ± 0.30
88.61 ± 0.43
91.26 ± 1.27
83.25 ± 1.40
82.91 ± 1.30
74.03 ± 0.86
DPPH free radicals scavenging effect
Hydrogen peroxide free radicals scavenging effect
ABTS free radicals scavenging effect
Correlation of total phenolic contents and various activities
Antioxidant compounds are useful neuroprotective agents in the therapy of early stages of Alzheimer’s disease (AD) . Though exact origin of AD is unknown, the diminution of neurotransmitters like ACh caused by the enzymes AChE and BChE are clearly involved in the etiology of this disease . One treatment strategy is to enhance cholinergic functions by the use of AChE and BChE inhibitors to augment the amount of ACh present in the synapses between cholinergic neurons. In this regard, use of selective inhibitors for AChE and BChE has attracted particular attention in the treatment of the Alzheimer-type dementia . In recent times, BChE received particular attention since it is a co-regulator of cholinergic neurotransmission and its pharmacological activity is increased in AD and associated with all neuropathological lesions in this disorder . Even though selective inhibitors of BChE from synthetic origin, based on quinazolinimines and lipoic acid have been reported . The search for more efficient and less expensive natural substances is a mandatory research branch . Use of AChE inhibitors like physostigmine or tacrine is restricted due to limitations such as short half life and serious side effects like hepatotoxicity. Alkylpyridium polymers, dehydroevodiamine (DHED) and carbamate type AChE inhibitors have been recently reported, but due to bioavailability problems and side effects, there is still great interest in searching better AChE inhibitors from natural sources .
Results of the current study revealed that Ir.Flv, Ir.Cf and Ir.Sp possesses highest inhibitory potential against AChE causing 87.44 ± 0.51, 83.73 ± 0.64 and 77.85 ± 0.56% enzyme inhibitions respectively at 1 mg/ml concentration. These fractions were most potent among others with IC50 values of 45, 50 and 75 μg/ml. AChE inhibitory activities of these fractions were comparable to standard drug galanthamine, whose percent inhibition was 96.00 ± 0.30 at the same tested concentration with IC50 of 20 μg/ml. In BChE inhibition assay, Ir.Cf, Ir.Flv and Ir.EtAc were found most active causing 88.55 ± 0.77, 82.53 ± 0.71 and 72.66 ± 0.78% enzyme inhibition at 1 mg/ml respectively. Median inhibitory concentrations (IC50) for these fractions were 70, 40 and 52 μg/ml respectively. Activities of these fractions were comparable to standard drug galanthamine at the same tested concentration. Among different fractions, Ir.Cf exhibited high phenolic (82.60 ± 0.68) and flavonoid (91.45 ± 1.12) contents, which can be linked to its highest enzyme inhibitory activities.
The use of antioxidants may slow the development of Alzheimer’s disease (AD) and diminish neuronal degeneration [35, 36]. Due to deteriorating effects of oxidative stress on human health the interest in naturally occurring antioxidant has been increased . The flavonoids are reported to possess strong BChE inhibitory potential . The age related brain performance can be improved by the use of vegetables and fruits rich in flavonoids which have the capability to neutralize the free radicals . The total phenolic and flavonoid contents can be correlated with the antioxidant potential against free radicals which can lead to cognitive aging and CNS disorders . Phenolic acids have been reported as natural radical scavengers in vegetables, fruits and herbs by several researchers . The antioxidant potential of phenolics is attributed to their redox properties which enables them to give hydrogen or quench the singlet oxygen .
The concentrations of the crude plant extracts that inhibited the DPPH, H2O2 and ABTS radicals by 50% (IC50) are presented in the Figure 1. In DPPH free radicals scavenging assay, Ir.Sp, Ir.Flv, Ir.EtAc and Ir.Cf were found most potent with IC50 of 0.1, 19, 22 and 28 μg/ml respectively. In H2O2 scavenging assay, Ir.Flv, Ir.EtAc and Ir.Cf proved IC50 of 24, 30 and 34 μg/ml respectively. Likewise, in ABTS free radicals scavenging activity, Ir,Cr, Ir.Aq and Ir.Sp exhibited IC50 of 37, 55 and 70 μg/ml respectively. In Linear correlation of total phenolic contents vs DPPH, H2O2 and ABTS radicals scavenging activities, these exhibited correlation coefficient of R2 = 0.641, 0.742 and 0.415 respectively (Figure 5C, D and E). Concentrations of phenolics in different fractions correlated well to antioxidant and anticholinestrase activities. The current investigations suggest that I. rugosus is a good source of anticholinesterase and antioxidant compounds. The fractions showing highest activities should be further subjected to isolation of novel, cost effective and safer active compounds useful in the treatment of neurological disorders.
Based on the current investigations it may be concluded that the Ir.Flv, Ir.Sp and Ir.Cf isolated from I. rugosus exhibited anticholinesterase and antioxidant activities comparable to that of standard drugs which can be attributed to their high phenolic contents. The current study suggests further investigations of I. rugosus for isolation, purification and characterization of valuable bioactive compounds for the treatment of various neurodegenerative diseases.
Plant collection and extraction
The aerial parts of I. rugosus were collected from Dir (U) Khyber Pakhtunkhwa, Pakistan in May 2013. The plant was identified by plant taxonomist at the department of Botany, Shaheed Benazir Bhutto University, Sheringal Dir (U) KP, Pakistan. The plant specimen was deposited at the herbarium of the same University with voucher number (1016AZ). The plant material was cleaned from dust with tap water and then with distilled water till the complete removal of all the extra particles. It was spread on a clean paper and shade dried for 23 days. The plant material was converted into coarse powder with the help of a grinder. The powdered material (11 kg) was soaked in 80% methanol for 15 days and was filtered. The filtrated solution was concentrated under reduced pressure using rotary evaporator (Heidolph Laborota 4000, Schwabach, Germany) at 40°C. Finally, the crude methanolic extract (900 g) was obtained.
The crude methanolic extract having weight of 900 g was added to separating funnel and mixed with 500 mL of n-hexane, chloroform and ethyl acetate and fractionated by successive solvent-solvent extraction method starting from the low polar solvent towards the high polar solvent using method described previously . Finally, Ir.Hex, Ir.Cf, Ir.EtAc and Ir.Aq obtained were 30 g, 45 g, 50 g and 180 g respectively.
Extraction of crude saponins
Crude saponins from Isodon rugosus were extracted by adding 20 g of the plant sample in a conical flask having 100 mL of 20% ethanol. This mixture was heated on water bath at 55°C for 4 h followed by filtration. The residue obtained was extracted again with 200 mL of 20% ethanol and was added to the first collection. Volume of solvent extract was reduced to 40 ml using water bath to obtained greenish color residue. The residue was transferred into a separating funnel and diethyl ether (20 mL) was added to it. After vigorous shaking, the separating funnel was put in a stand to get two layers. The upper organic layer was discarded while the lower aqueous layer obtained was diluted with 60 mL of n-butanol. This combined n- butanol extract was washed twice with 10 ml of 5% NaCl solution. The solution was evaporated by keeping in water bath to obtain the dried saponins .
Extraction of crude flavonoids
Harborne’s procedure was followed for the isolation of crude flavonoids . Plant sample having weight of 20 g was taken in powdered form and heated in 200 ml of 2 M HCl at 50°C under reflux for 30 minutes. It was allowed to cold and then filtered using whatman No.42 filter paper. The filtrate was treated with equal volume of ethyl acetate. The flavonoids present in the extract were precipitated, which was recovered with the help of weighed filter paper. The weight of flavonoids obtained was 1.5 grams (7.5%).
Determination of total phenolic contents
The total phenolic contents was determined following the procedure reported previously . Briefly, 1 ml of diluted extract was mixed with 9 ml of distilled water followed by addition of 1 ml of Folin-Ciocalteu’s reagent (FCR) with vigorous shaking. After 5 min, 10 ml of 7% Na2CO3 solution was added to it and properly mixed. The mixture was diluted to 25 ml with distilled water and shaken properly. After 90 min, the absorbance was measured by using UV spectrophotometer at 750 nm. Gallic acid standard curve was used for the measurement of total phenolic contents. The total phenolics were expressed as milligrams of gallic acid equivalent (mg GAE/g) per gram of dry sample.
Determination of total flavonoids contents
Total flavonoid contents of Isodon rugosus were determined using procedure previously described . Briefly, 0.3 ml of plant sample solution, 0.15 ml NaNO2 (0.5 M), 3.4 ml methanol (30%) and 0.15 ml AlCl3.6H2O (0.3 M) were mixed and added to a 10 ml test tube. After 5 min, 1 ml of NaOH (1.0 M) was added to it. The absorbance of the mixture was measured by using UV spectrophotometer at 506 nm. For the determination of total flavonoids, standard Rutin solution curve (0 to 100 mg/l) was used. The total flavonoid contents were expressed as milligram of rutin equivalent per gram of dry sample (mg RTE/g).
Chemicals and drugs
Potassium phosphate buffer (pH 8.0), Galantamine from Lycoris Sp. (Sigma-Aldrich France), Butyrylthiocholin iodide (Sigma-Aldrich Switzerland), Acetylthiocholine Iodide (Sigma-Aldrich UK), 5,5-dithio-bis-nitrobenzoic acid (DTNB) (Sigma-Aldrich Germany), Electric eel acetylcholinesterase (type-VI-S, Sigma-Aldrich USA) and Aquine butyrylcholinesterase (Sigma-Aldrich USA) were used in enzyme inhibition assays. For antioxidant assays, DPPH (Sigma Aldrich CHEMIE GmbH USA), H2O2 (Riedel-de Haen Germany) and ABTS (Sigma-Aldrich Germany) were used. All solvents used in the assays were of analytical grades purchased from Sigma-Aldrich.
In this method, plant samples were evaluated spectrophotometrically for AChE and BChE inhibition potentials using acetylthiocholine iodide and Butyrylthiocholine iodide as substrates, respectively following Ellman assay . In this method, 205 μl of plant samples (125–1000 μg/ml) were added to the cuvette contained BChE (0.01 U/ml) and 5 μl of AChE (0.03 U/ml). DTNB (5 μl) was added to the mixture and incubated for 15 min in a water bath having temperature of 30°C. To start the reaction added 5 μl substrates to the mixture. Absorbance was measured using double beam Spectrophotometer at wavelength of 412 nm for 4 min.
(Where V indicates the rate of reaction in the presence of inhibitor and Vmax is the rate of reaction without inhibitor).
DPPH free radicals scavenging activity
Hydrogen peroxide free radicals scavenging activity
ABTS free radicals scavenging activity
Each experiment was performed in three replicates and values were expressed as mean ± SEM. One way ANOVA followed by multiple comparison Dunnett's test was used for the comparison of positive control with the test groups. The P values less than 0.05 were considered as statistically significant. IC50 values were calculated by a linear regression analysis among the percent inhibition against the extract concentrations via Excel program.
Regression and linear correlation
Regression (y) and linear correlation (R2) for phenolic contents and various activities (anticholinesterase and antioxidants) were determined using Microsoft Excel 2007.
The authors are grateful to the Department of Pharmacy for the kind provision of research laboratories for conduction of these activities. We are also thankful to Dr. Ali Hazrat, Department of Botany, SBBU, Sheringal, Dir Upper, Pakistan for identification of plant.
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
- Kamal MA, Al-Jafari AA, Yu Q-S, Greig NH: Kinetic analysis of the inhibition of human butyrylcholinesterase with cymserine. Biochim Biophys Acta BBA-Gen Subj 2006, 1760(2):200-206. 10.1016/j.bbagen.2005.10.003View ArticleGoogle Scholar
- Ellis JM: Cholinesterase inhibitors in the treatment of dementia. J Am Osteopath Assoc 2005, 105: 145-158.PubMedGoogle Scholar
- Giacobini E: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications. Neurochem Int 1998, 32: 413-419. 10.1016/S0197-0186(97)00124-1View ArticlePubMedGoogle Scholar
- Krall W, Sramek J, Cutler N: Cholinesterase inhibitors: a therapeutic strategy for Alzheimer's disease. Ann Pharmacother 1999, 33: 441-450. 10.1345/aph.18211View ArticlePubMedGoogle Scholar
- Rahman A, Choudhary M: Bioactive natural products as a potential source of new pharmacophores a theory of memory. Pure Appl Chem 2001, 73: 555-560.Google Scholar
- Brenner G: Pharmacology. Philadelphia: WB Saunders Company; 2000.Google Scholar
- Oh M, Houghton P, Whang W, Cho J: Screening of Korean herbal medicines used to improve cognitive function for anti-cholinesterase activity. Phytomedicine 2004, 11: 544-548. 10.1016/j.phymed.2004.03.001View ArticlePubMedGoogle Scholar
- Schulz V: Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trial and guidelines fail to consider. Phytomedicine 2003, 10: 74-79.View ArticlePubMedGoogle Scholar
- Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW: Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. Jama 1994, 271: 992-998. 10.1001/jama.1994.03510370044030View ArticlePubMedGoogle Scholar
- Zhu X, Raina A, Lee H, Casadesus G, Smith M, Perry G: Oxidative stress signaling in Alzheimer's disease. Brain Res 2004, 1000: 32-39. 10.1016/j.brainres.2004.01.012View ArticlePubMedGoogle Scholar
- Lobo V, Patil A, Phatak A, Chandra N: Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev 2010, 4(8):118-126. 10.4103/0973-7847.70902PubMed CentralView ArticlePubMedGoogle Scholar
- Erejuwa O, Sulaiman SA, Wahab MS: Honey: a novel antioxidant. Molecules 2012, 17: 4400-4423. 10.3390/molecules17044400View ArticlePubMedGoogle Scholar
- Zambonin L, Caliceti C, Sega F, Fiorentini D, Hrelia S, Landi L: Dietary phenolic acids act as effective antioxidants in membrane models and in cultured cells, exhibiting proapoptotic effects in leukaemia cells. Oxid Med Cell Longev 2012, 2012: 1-12.View ArticleGoogle Scholar
- Gordon A, Cruz A, Cabral L, Cordeiro de Freitas S, Taxi C, Donangelo C: MChemical characterization and evaluation of antioxidant properties of Acai fruits ( Euterpe oleraceae Mart.) during ripening. Food Chem 2012, 133: 256-263. 10.1016/j.foodchem.2011.11.150View ArticlePubMedGoogle Scholar
- Barlow S: Toxicological aspects of antioxidants used as food additives. In Food Antioxidants. Edited by: Hudson BJF. London: Elsevier; 1990:253-307.View ArticleGoogle Scholar
- Zia-Ul-Haq M, Riaz M, De Feo V, Jaafar HZ, Moga M: Rubus fruticosus L.: constituents, biological activities and health related uses. Molecules 2014, 19(8):10998-11029. 10.3390/molecules190810998View ArticlePubMedGoogle Scholar
- Shah SM, Ayaz M, Khan A-u, Ullah F, Iqbal H, Hussain S: 1, 1-Diphenyl, 2-picrylhydrazyl free radical scavenging, bactericidal, fungicidal and leishmanicidal properties of Teucrium stocksianum . Toxicol Ind Health 2013. doi:10.1177/0748233713487250Google Scholar
- Kil HY, Seong ES, Ghimire BK, Chung I-M, Kwon SS, Goh EJ, Heo K, Kim MJ, Lim JD, Lee D: Antioxidant and antimicrobial activities of crude sorghum extract. Food Chem 2009, 115: 1234-1239. 10.1016/j.foodchem.2009.01.032View ArticleGoogle Scholar
- Ayaz M, Junaid M, Ahmed J, Ullah F, Sadiq A, Ahmad S, Imran M: Phenolic contents, antioxidant and anticholinesterase potentials of crude extract, subsequent fractions and crude saponins from Polygonum hydropiper L. BMC Complement Altern Med 2014, 14: 145. 10.1186/1472-6882-14-145PubMed CentralView ArticlePubMedGoogle Scholar
- Shahidi F, Wanasundara P: Phenolic antioxidants. Crit Rev Food Sci Nutr 1992, 32: 67-103. 10.1080/10408399209527581View ArticlePubMedGoogle Scholar
- Fujita E, Node M: Diterpenoids of Rabdosia species. In Fortschritte der Chemie organischer Naturstoffe/Progress in the Chemistry of Organic Natural Products. Vienna: Springer; 1984:77-157.View ArticleGoogle Scholar
- Faizul H, Habib A, Mukhtar A: Traditional uses of medicinal plants of Nandiar Khuwarr catchment (District Battagram), Pakistan. J Med Plants Res 2011, 5(1):39-48.Google Scholar
- Collins M, Charles H: Antimicrobial activity of Carnosol and Ursolic acid: two anti-oxidant constituents of Rosmarinus officinalis L. Food Microbiol 1987, 4: 311-315. 10.1016/S0740-0020(87)80005-9View ArticleGoogle Scholar
- Wojdyło A, Oszmiański J, Czemerys R: Antioxidant activity and phenolic compounds in 32 selected herbs. Food Chem 2007, 105: 940-949. 10.1016/j.foodchem.2007.04.038View ArticleGoogle Scholar
- Khan SW, Khatoon S: Ethnobotanical studies on useful trees and shrubs of Haramosh and Bugrote valleys, in Gilgit northern areas of Pakistan. Pak J Bot 2007, 39(3):699-710.Google Scholar
- Adnan M, Begum S, Khan AL, Tareen AM, Lee I-J: Medicinal plants and their uses in selected temperate zones of Pakistani Hindukush-Himalaya. J Med Plants Res 2012, 6: 4113-4127.Google Scholar
- Duh P-D, Tu Y-Y, Yen G-C: Antioxidant activity of water extract of Harng Jyur ( Chrysanthemum morifolium Ramat). LWT-Food Sci Technol 1999, 32: 269-277. 10.1006/fstl.1999.0548View ArticleGoogle Scholar
- Hatano T, Edamatsu R, Hiramatsu M, Mori A, Fujita Y, Yasuhara T, Yoshida T, Okuda T: Effects of the interaction of tannins with co-existing substances. VI: effects of tannins and related polyphenols on superoxide anion radical, and on 1, 1-diphenyl-2-picryl hydrazyl radical. Chem Pharm Bull 1989, 37: 2016-2021. 10.1248/cpb.37.2016View ArticleGoogle Scholar
- Decker M, Kraus B, Heilmann J: Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant properties. Bioorg Med Chem 2008, 16: 4252-4261. 10.1016/j.bmc.2008.02.083View ArticlePubMedGoogle Scholar
- Piazzi L, Belluti F, Bisi A, Gobbi S, Rizzo S, Bartolini M, Andrisano V, Recanatini M, Rampa A: Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino) alkoxy] xanthen-9-ones. Bioorg Med Chem 2006, 15(1):575-585.View ArticlePubMedGoogle Scholar
- Kim W-G, Cho K-M, Lee C-K, Yoo I-D: Terreulactone A, a novel meroterpenoid with anti-acetylcholinesterase activity from Aspergillus terreus . Tetrahedron Lett 2002, 43: 3197-3198. 10.1016/S0040-4039(02)00465-3View ArticleGoogle Scholar
- Darvesh S, McDonald RS, Darvesh KV, Mataija D, Conrad S, Gomez G, Walsh R, Martin E: Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine. Bioorg Med Chem 2007, 15(19):6367-6378. 10.1016/j.bmc.2007.06.060View ArticlePubMedGoogle Scholar
- Lobo V, Patil A, Phatak A, Chandra N: Free radicals, antioxidants and functional foods: Impact on human health. Pharmacog Rev 2010, 4: 118. 10.4103/0973-7847.70902View ArticleGoogle Scholar
- Schneider LS: New therapeutic approaches to Alzheimer's disease. J Clin Psychiatry 1995, 57: 30-36.Google Scholar
- Choudhary MI: Bioactive natural products as a potential source of new pharmacophores. A theory of memory. Pure Appl Chem 2001, 73: 555-560.Google Scholar
- Howes MJR, Perry NS, Houghton PJ: Plants with traditional uses and activities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother Res 2003, 17: 1-18. 10.1002/ptr.1280View ArticlePubMedGoogle Scholar
- Scalbert A, Manach C, Morand C, Rémésy C, Jiménez L: Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 2005, 45: 287-306. 10.1080/1040869059096View ArticlePubMedGoogle Scholar
- Noor A-t, Fatima I, Ahmad I, Malik A, Afza N, Iqbal L, Latif M, Khan SB: Leufolins A and B, potent butyrylcholinesterase-inhibiting flavonoid glucosides from Leucas urticifolia . Molecules 2007, 12: 1447-1454. 10.3390/12071447View ArticleGoogle Scholar
- Youdim KA, Shukitt-Hale B, Joseph JA: Flavonoids and the brain: interactions at the blood–brain barrier and their physiological effects on the central nervous system. Free Radic Biol Med 2004, 37: 1683-1693. 10.1016/j.freeradbiomed.2004.08.002View ArticlePubMedGoogle Scholar
- Golden TR, Hinerfeld DA, Melov S: Oxidative stress and aging: beyond correlation. Aging Cell 2002, 1: 117-123. 10.1046/j.1474-9728.2002.00015.xView ArticlePubMedGoogle Scholar
- Larson RA: The antioxidants of higher plants. Phytochemistry 1988, 27: 969-978. 10.1016/0031-9422(88)80254-1View ArticleGoogle Scholar
- Rice-evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB: The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Rad Res 1995, 22: 375-383. 10.3109/10715769509145649View ArticleGoogle Scholar
- Ayaz M, Junaid M, Subhan F, Ullah F, Sadiq A, Ahmad S, Imran M, Kamal Z, Hussain S, Shah SM: Heavy metals analysis, phytochemical, phytotoxic and anthelmintic investigations of crude methanolic extract, subsequent fractions and crude saponins from Polygonum hydropiper L. BMC Complement Altern Med 2014, 14: 465. 10.1186/1472-6882-14-465PubMed CentralView ArticlePubMedGoogle Scholar
- Zeb A, Sadiq A, Ullah F, Ahmad S, Ayaz M: Phytochemical and toxicological investigations of crude methanolic extracts, subsequent fractions and crude saponins of Isodon rugosus . Biol Res 2014, 47(1):57. 10.1186/0717-6287-47-57PubMed CentralView ArticlePubMedGoogle Scholar
- Harborne A: Phytochemical methods a guide to modern techniques of plant analysis. London: Springer; 1998.Google Scholar
- Kim D-O, Jeong SW, Lee CY: Antioxidant capacity of phenolic phytochemicals from various cultivars of plums. Food Chem 2003, 81(3):321-326. 10.1016/S0308-8146(02)00423-5View ArticleGoogle Scholar
- Park H-H, Lee S, Son H-Y, Park S-B, Kim M-S, Choi E-J, Singh TS, Ha J-H, Lee M-G, Kim J-E: Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch Pharm Res 2008, 31(10):1303-1311. 10.1007/s12272-001-2110-5View ArticlePubMedGoogle Scholar
- Classics Ellman GL, Courtney KD, Andres V, Featherstone RM: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961, 7: 88-95. 10.1016/0006-2952(61)90145-9View ArticleGoogle Scholar
- Brand-Williams W, Cuvelier M, Berset C: Use of a free radical method to evaluate antioxidant activity. LWT-Food Sci Technol 1995, 28: 25-30. 10.1016/S0023-6438(95)80008-5View ArticleGoogle Scholar
- Ruch RJ, Cheng S-J, Klaunig JE: Prevention of cytotoxicity and inhibition of intercellular communication by antioxidant catechins isolated from Chinese green tea. Carcinogenesis 1989, 10: 1003-1008. 10.1093/carcin/10.6.1003View ArticlePubMedGoogle Scholar
- Re R, Pellegrini N, Proteggente A, Pannala A, Yong M, Rice-Evas C: Antioxidant activity applying an improved FBTS radical cation decolorization assay. Free Rad Biol Med 1999, 26(9/10):1231-1237.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.